Treatment strategies in coronary microvascular dysfunction: A systematic review of interventional studies

Hannah E Suhrs1, Marie M Michelsen1, Eva Prescott1

  • 1Department of Cardiology, Bispebjerg University Hospital, Copenhagen NV, Denmark.

Microcirculation (New York, N.Y. : 1994)
|November 14, 2017
PubMed

Insights

Current treatments for coronary microvascular dysfunction (CMD) lack guideline recommendations due to insufficient evidence. Larger, well-designed trials are needed to establish effective, individualized therapies for this condition.

Area of Science:

  • Cardiology
  • Clinical Research
  • Pharmacology

Background:

  • Coronary microvascular dysfunction (CMD) is linked to numerous diseases and predicts morbidity/mortality.
  • Despite its significance, evidence-based treatment guidelines are absent.

Purpose of the Study:

  • To systematically review pharmacological and non-pharmacological interventions for improving coronary perfusion in CMD.
  • To assess the efficacy of various diagnostic techniques for evaluating coronary microvascular function.

Main Methods:

  • Systematic review of 80 studies meeting inclusion criteria, sourced from 4485 records.
  • Included studies encompassed diverse designs (randomized, non-randomized) and cardiac conditions.
  • Interventions were evaluated using imaging modalities like IC Doppler, TTDE, PET, CMRI, and echocardiography.

Main Results:

  • Studies were generally small and methodologically heterogeneous, with few placebo-controlled trials.
  • While some interventions showed promise, none were sufficiently documented for broad recommendation.
  • No specific treatment could be recommended for any patient group based on current evidence.

Conclusions:

  • There is a critical need for larger, well-designed clinical trials in CMD.
  • Future research should stratify patients by pathogenic mechanisms to explore individualized treatment efficacy.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
314
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
380
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
313
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
328
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
460
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
493